Allan Vaag

Allan Vaag

Affiliate Professor


  1. Published

    Anti-diabetic treatment, insulin resistance and cardiovascular disease in patients with type 2 diabetes

    Hemmingsen, B., Lund, S. S. & Vaag, Allan, 2009, In: Ugeskrift for læger. 171, 19, p. 1598-1602 4 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Published

    Oral hypoglycaemic agents, insulin resistance and cardiovascular disease in patients with type 2 diabetes

    Hemmingsen, B., Lund, S. S., Wetterslev, J. & Vaag, Allan, 2009, In: European Journal of Endocrinology. 161, 1, p. 1-9 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    Intensive glycaemic control for patients with type 2 diabetes: systematic review with meta-analysis and trial sequential analysis of randomised clinical trials

    Hemmingsen, B., Lund, S., Gluud, C. N., Vaag, Allan, Almdal, T., Hemmingsen, C. & Wetterslev, J., Nov 2011, In: B M J. 343, p. d6898

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published

    Sulphonylurea monotherapy for patients with type 2 diabetes mellitus

    Hemmingsen, B., Schroll, J. B., Lund, S., Wetterslev, J., Gluud, C., Vaag, Allan, Sonne, David Peick, Lundstrøm, Lars Hyldborg & Almdal, Thomas Peter, 2013, In: Cochrane Database of Systematic Reviews. 4, 56 p., CD009008.

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Published

    Antidiabetika, insulinresistens og hjerte-kar-sygdom hos patienter med type 2-diabetes

    Hemmingsen, B., Lund, S. S. & Vaag, Allan, 2009, In: Ugeskrift for læger. 171, 19, p. 1598-602 4 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  6. Published

    Comparison of metformin and insulin versus insulin alone for type 2 diabetes: systematic review of randomised clinical trials with meta-analyses and trial sequential analyses

    Hemmingsen, B., Christensen, L. L., Wetterslev, J., Vaag, Allan, Gluud, C., Lund, S. & Almdal, T., 2012, In: B M J. 344, p. e1771

    Research output: Contribution to journalJournal articleResearchpeer-review

  7. Published

    Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus

    Hemmingsen, B., Lund, S., Gluud, C. N., Vaag, Allan, Almdal, Thomas Peter, Hemmingsen, C. & Wetterslev, J., 2011, In: Cochrane Database of Systematic Reviews. 6, p. CD008143

    Research output: Contribution to journalJournal articleResearchpeer-review

  8. Published

    Sulfonylurea versus metformin monotherapy in patients with type 2 diabetes: a Cochrane systematic review and meta-analysis of randomized clinical trials and trial sequential analysis

    Hemmingsen, B., Schroll, J. B., Wetterslev, J., Gluud, C., Vaag, Allan, Sonne, D. P., Lundstrøm, L. H. & Almdal, Thomas Peter, Jul 2014, In: CMAJ open. 2, 3, p. E162-175 14 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  9. Published

    Intensive glycaemic control for patients with type 2 diabetes: systematic review with meta-analysis and trial sequential analysis of randomised clinical trials. (Rapid response)

    Hemmingsen, B., Lund, S. S., Gluud, C., Vaag, Allan, Almdal, T. P. & Wetterslev, J., 2012, In: B M J. 344, p. e710

    Research output: Contribution to journalLetterResearchpeer-review

  10. Published

    Dysregulation of a novel miR-23b/27b-p53 axis impairs muscle stem cell differentiation of humans with type 2 diabetes

    Henriksen, T. I., Davidsen, P. K., Pedersen, M., Schultz, H. S., Hansen, N. S., Larsen, T. J., Vaag, Allan, Pedersen, Bente Klarlund, Nielsen, S. & Schéele, Camilla Charlotte Nielsen, 2017, In: Molecular Metabolism. 6, 7, p. 770-779 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

Previous 1...5 6 7 8 9 10 11 12 ...24 Next

ID: 987205